Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus GG + Metronidazole for CDAD
NCT00304863Phase 4Withdrawn
- Sponsor
- Michael E. DeBakey VA Medical Center
- Start
- Aug 2008
- Primary completion
- Jul 2010
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of Lactobacillus rhamnosus GG in Clostridium difficile infection (CDI), sponsored by Michael E. DeBakey VA Medical Center. Planned start Aug 2008; status: withdrawn.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT00304863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304863.